Sort
48,018 grants matching “immunotherapy”
Pathogenesis of Postoperative Cognitive Dysfunction
$403,498Zhongcong Xie · Massachusetts General Hospital · R01 · FY2016 · AG
EGFRvIII-targeted Bispecific T cell Engagers for brain tumors
$403,487John H Sampson · Duke University · R01 · FY2016 · NS
Development of new Pt-based ROS storm inducing polymers with tumor specific toxicity
$403,485Junhua Mai · Methodist Hospital Research Institute · R21 · FY2025 · CA
GENE-BASED THERAPIES AND IMAGING OF MALIGNANT GLIOMAS
$403,424University Of Pennsylvania · R01 · FY2003 · CA
Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2
$403,419Dai Fukumura · Massachusetts General Hospital · R01 · FY2021 · NS
Reprogramming the tumor microenvironment to improve immunotherapy of glioblastoma by co-targeting VEGF and Ang2
$403,419Dai Fukumura · Massachusetts General Hospital · R01 · FY2022 · NS
Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2
$403,419Dai Fukumura · Massachusetts General Hospital · R01 · FY2023 · NS
Genetic and molecular mechanisms of replication of araC damaged DNA
$403,401Satya Prakash · University Of Texas Med Br Galveston · R01 · FY2020 · CA
Genetic and molecular mechanisms of replication of araC damaged DNA
$403,401Satya Prakash · University Of Texas Med Br Galveston · R01 · FY2017 · CA
Regulation of stem-like CD8+ T cells and their role in immunotherapy
$403,393Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2025 · CA
Regulation of stem-like CD8+ T cells and their role in immunotherapy
$403,366Ana C Anderson · Brigham And Women'S Hospital · R01 · FY2022 · CA
Human Anti-Macaque CCR5 Mabs for Passive Immunotherapy
$403,328Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2007 · AI
Cell Therapy Core: GMP/Vector Labs
$403,321Indreshpal Kaur · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
Targeting the colchicine binding site in tubulin for cancer therapy
$403,307Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2021 · CA
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$403,284Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2020 · CA
Small Molecule Activators of Procaspases as Anti-Cancer Agents
$403,281Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2021 · CA
T cell plasticity, fusion proteins and CAR T cell-based immunotherapy of head and neck cancer
$403,238Soldano Ferrone · Massachusetts General Hospital · R01 · FY2018 · DE
Human epidemiology and response to SARS-CoV-2 (HEROS)
$403,137Daniel J Jackson · University Of Wisconsin-Madison · UM1 · FY2021 · AI
Administrative Core
$403,118Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2021 · CA
The Unique Roles of Tumor-Specific Th9 Cells for Solid Tumor Eradication
$403,102Yong Lu · Methodist Hospital Research Institute · R01 · FY2022 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer
$403,102Trudy Gale Oliver · Duke University · R01 · FY2023 · CA
Viral Resistance to Antiviral Therapy for Hepatitis C
$403,079University Of Maryland Baltimore · M01 · FY2004 · RR
Mechanisms of Immune Evasion by Hepatitis C Virus
$403,000Andrea L Cox · Johns Hopkins University · R01 · FY2009 · AI
Role and Utility of Annexins in Endothelium of Solid Tum
$402,978Jan E Schnitzer · Sidney Kimmel Cancer Center · R01 · FY2007 · CA
Role and Utility of Annexins in Endothelium of Solid Tum
$402,978Jan E Schnitzer · Sidney Kimmel Cancer Center · R01 · FY2008 · CA